Trending Now
Acadia Pharmaceuticals (NASDAQ:ACAD) Reports NUPLZID® Net Sales Of $120.6 Million In...
Acadia Pharmaceuticals (NASDAQ:ACAD) has announced its Q3 2020 financial results in which net sales were up 27% YoY to $120.6 million.
Pimavanserin sales drove Acadia’s...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Novavax (NASDAQ:NVAX) Stock Jumps 11% On Plans To Commence Vaccine Trials...
Novavax (NASDAQ:NVAX) stock popped 11% on Monday after the company announced updates from its COVID-19 vaccine trials. The company expects to releases results from...
MAKE IT MODERN
LATEST REVIEWS
Fulcrum Therapeutics, Inc (NASDAQ: FULC) Says the Unveiled Proof-Of-Concept For FTX-6058...
Fulcrum Therapeutics, Inc (NASDAQ: FULC) has spoken about its ongoing Phase 1b trial of FTX-6058, whose goal is to develop a working...
MAKE IT MODERN
PERFORMANCE TRAINING
Applied DNA Sciences Inc (APDN) could keep surging and here’s why
Shares of Applied DNA Sciences Inc (APDN) are currently trading at 2.7650 with a gain of over $0.7650 (+38.2500%). The stock is...
Nantkwest Inc (NASDAQ:NK) And ImmunityBio Jointly Announce Initial Patient Dosing In Phase 1 Clinical...
Nantkwest Inc (NASDAQ:NK) and ImmunityBio recently announced an important milestone in the development of their second generation COVID-19 vaccine called hAd5-COVID-19.
The two companies revealed...
Moderna Inc‘s (NASDAQ: MRNA) Chair Noubar Afeyan Explains How They Leveraged mRNA Technology To...
Moderna (NASDAQ: MRNA) Char Noubar Afeyan has explained how his combination of science with business acumen led to the creation of a vaccine to...
Nio Inc (NYSE:NIO) gets an upgrade from Bank of America
The year 2022 has been nothing but dismal for share holders of Nio Inc (NIO). Share prices have lost over 50% value...
Equilibrium Inc. (NASDAQ:EQ) Receives Positive Feedback From the FDA On Itolizimab Treating Hospitalized COVID-19...
Equillum Inc. (NASDAQ:EQ) has announced the completion of an FDA pre-investigational New Drug (IND) meeting under the Coronavirus Treatment Acceleration Program (CTAP).
Positive FDA feedback...
MAKE IT MODERN
